Karl Anders Olof Harfstrand - 17 May 2023 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Michael J. Malecek, as attorney-in-fact for Karl Anders O. Harfstrand
Issuer symbol
PRTA
Transactions as of
17 May 2023
Transactions value $
$0
Form type
4
Filing time
19 May 2023, 21:30:53 UTC
Previous filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Award $0 +15K $0.00 15K 17 May 2023 Ordinary Shares 15K $76.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.